Rallybio Corporaton (RLYB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,978 | -57,775 | -74,564 | -66,654 | -47,013 |
| Depreciation Amortization | -481 | -1,481 | -2,939 | -268 | 109 |
| Accounts payable and accrued liabilities | -152 | -698 | -99 | 487 | -976 |
| Other Working Capital | -4,192 | -258 | 4,277 | -936 | -3,779 |
| Other Operating Activity | -16,010 | 10,930 | 13,060 | 10,087 | 6,126 |
| Operating Cash Flow | $-29,813 | $-49,282 | $-60,265 | $-57,284 | $-45,533 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -12 | -54 | -333 |
| Purchase Of Investment | -19,197 | -50,933 | -110,664 | -201,616 | -2,000 |
| Sale Of Investment | 46,465 | 84,425 | 138,334 | 89,500 | N/A |
| Other Investing Activity | 20,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $47,268 | $33,492 | $27,658 | $-112,170 | $-2,333 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 16 | 5,467 | 282 | 51,771 | 86,200 |
| Other Financing Activity | 0 | -268 | -139 | -693 | -3,233 |
| Financing Cash Flow | $16 | $5,199 | $143 | $51,078 | $82,967 |
| Beginning Cash Position | 13,903 | 24,494 | 56,958 | 175,334 | 140,233 |
| End Cash Position | 31,374 | 13,903 | 24,494 | 56,958 | 175,334 |
| Net Cash Flow | $17,471 | $-10,591 | $-32,464 | $-118,376 | $35,101 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,813 | -49,282 | -60,265 | -57,284 | -45,533 |
| Capital Expenditure | N/A | N/A | -12 | -54 | -333 |
| Free Cash Flow | -29,813 | -49,282 | -60,277 | -57,338 | -45,866 |